In the LIPGENE-SU.VI.MAX study GG homozygotes of rs3790433 SNP at the LEPR gene had increased MetS risk compared with the minor A allele carriers (OR 1.65), which may be accounted for by their increased risk of elevated insulin concentrations and insulin resistance [104]. The gene discussed is INS; the disease is metabolic syndrome.